清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

Preclinical Characterization of NGM936, a Novel Bispecific T Cell Engager Targeting ILT3 for the Treatment of Acute Myeloid Leukemia with Monocytic Differentiation

髓系白血病 骨髓 髓样 白血病 造血 医学 癌症研究 抗原 祖细胞 免疫学 干细胞 生物 细胞生物学
作者
Vicky Y. Lin,Anjushree Iyer,Keith T. Akama,Rujin Cheng,Hong Yang,Jonathan Aguayo,Betty Li,Alan K. Kutach,Jie Tang,Daniel D. Kaplan,Julie M. Roda
出处
期刊:Blood [Elsevier BV]
卷期号:140 (Supplement 1): 9063-9064 被引量:5
标识
DOI:10.1182/blood-2022-160209
摘要

Acute myeloid leukemia (AML) with monocytic differentiation [M4 and M5 AML per the French-American-British (FAB) classification] accounts for 25-30% of all AML cases and has a particularly poor prognosis, with a <15% five-year overall survival rate and an increased risk of bone marrow and extramedullary relapse after stem cell transplant compared with other AML subtypes. The use of T cell engagers in AML has been limited by the lack of suitable target antigens with high specificity for AML cells and minimal expression on healthy bone marrow progenitors. Immunoglobulin-like transcript 3 (ILT3, also known as LILRB4) is a highly specific marker of AML with monocytic differentiation and is not expressed on non-monocytic blood cells or hematopoietic progenitor cells. This highly restricted expression profile makes ILT3 a promising target for monocytic AML, with the potential to enable effective elimination of AML cells with less toxicity than current therapies. Here, we report the pre-clinical characterization of NGM936, an ILT3-based T cell engager for the treatment of monocytic AML and other ILT3+ hematologic malignancies. NGM936 is a monovalent scFv-Fab bispecific on an effectorless human IgG1 backbone (LALA) with a knob-in-hole Fc design for heterodimeric assembly. NGM936 demonstrates sub-nM affinity towards ILT3 of human origin (KD = 0.2 nM at 25°C by surface plasmon resonance) and is not cross-reactive towards other LILRA/B family members. A panel of more than 30 ILT3 x CD3 engagers in various formats was generated and screened in assays to measure both T cell-dependent cytotoxicity and cytokine release. NGM936 was identified for its ability to potently induce T cell-dependent cytotoxicity (TDCC) against ILT3+ AML cells while inducing minimal cytokine release. In both whole blood cytokine release assays and in TDCC assays in which cytokine secretion was measured after target engagement, induction of TNF-α, IL-6, IFN-γ, and IL-2 by NGM936 was considerably lower than that induced by a vibecotamab biosimilar (CD123 x CD3). NGM936 induced potent cytotoxicity when both expanded and naïve T cells were used as effectors. Importantly, NGM936 efficiently ablated tumor cells with a range of ILT3 expression, from ~1500 copies/cell to ~40,000 copies/cell. In addition, NGM936 failed to induce T cell-dependent cytotoxicity against CD34+ hematopoietic stem cells or non-monocytic immune cells, consistent with the lack of ILT3 expression on these cell types. In ex vivo cultures of primary M5 AML bone marrow, NGM936 induced a dose-dependent depletion of AML cells and a concordant increase in T cell proliferation and activation. Finally, NGM936 induced a dose-dependent depletion of circulating tumor cells in a xenograft model in which irradiated, immunodeficient NSG mice were engrafted with human PBMCs and human ILT3+ AML cells. NGM936 thus represents a promising new treatment strategy for monocytic AML, with the potential to eliminate monocytic leukemia cells while minimizing the myelotoxicity associated with ablation of healthy bone marrow.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
乐乐的应助被tuimao采纳,获得10
2秒前
无私的碧玉完成签到,获得积分10
9秒前
丰富的德天完成签到 ,获得积分10
19秒前
科研通AI6.4的应助被TingtingGZ采纳,获得10
23秒前
简单完成签到 ,获得积分10
26秒前
外向的慕山完成签到,获得积分10
26秒前
笨笨盈完成签到,获得积分10
26秒前
35秒前
NN完成签到,获得积分10
43秒前
等待戈多发布了新的文献求助10
51秒前
笑点低的如萱完成签到,获得积分10
53秒前
TingtingGZ发布了新的文献求助10
53秒前
chenchen完成签到,获得积分10
59秒前
Wang发布了新的文献求助10
1分钟前
1分钟前
心灵美懿轩完成签到,获得积分10
1分钟前
无限鸣凤完成签到,获得积分10
1分钟前
linllll完成签到,获得积分10
1分钟前
魔幻的凝丝完成签到,获得积分10
1分钟前
我是老大的应助被TingtingGZ采纳,获得10
1分钟前
drkyy完成签到,获得积分10
1分钟前
顺利秋灵完成签到,获得积分10
1分钟前
等待戈多完成签到,获得积分10
1分钟前
漂亮的颤完成签到,获得积分10
2分钟前
2分钟前
TingtingGZ发布了新的文献求助10
2分钟前
科研通AI6.2的应助被TingtingGZ采纳,获得10
2分钟前
metoo完成签到,获得积分10
2分钟前
迷路曼荷完成签到,获得积分10
2分钟前
文艺的纸鹤完成签到,获得积分10
2分钟前
高兴战斗机完成签到,获得积分10
2分钟前
2分钟前
2分钟前
小胖子完成签到 ,获得积分10
2分钟前
ze完成签到 ,获得积分10
2分钟前
迷你的蜜粉完成签到,获得积分10
2分钟前
如意嘉熙完成签到,获得积分10
3分钟前
蜗牛好好飞完成签到,获得积分10
3分钟前
悦耳乘风完成签到,获得积分10
3分钟前
La完成签到,获得积分10
3分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8173213
求助须知:如何正确求助?哪些是违规求助? 9565567
关于积分的说明 21780496
捐赠科研通 7767342
什么是DOI,文献DOI怎么找? 3431542
关于科研通互助平台的介绍 2555730
邀请新用户注册赠送积分活动 2476697